CAM
ClariVest Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-80
| Closed | -$4.32K | – | 860 |
|
|
2024
Q1 | $4.32K | Buy |
80
+35
| +78% | +$1.89K | ﹤0.01% | 490 |
|
|
2023
Q4 | $2.31K | Sell |
45
-224,842
| -100% | -$11.5M | ﹤0.01% | 531 |
|
|
2023
Q3 | $13.1M | Sell |
224,887
-15,661
| -7% | -$909K | 0.71% | 31 |
|
|
2023
Q2 | $15.4M | Sell |
240,548
-44,700
| -16% | -$2.86M | 0.77% | 27 |
|
|
2023
Q1 | $19.8M | Sell |
285,248
-12,607
| -4% | -$874K | 0.88% | 20 |
|
|
2022
Q4 | $21.4M | Sell |
297,855
-7,956
| -3% | -$572K | 1.03% | 20 |
|
|
2022
Q3 | $21.7M | Sell |
305,811
-18,200
| -6% | -$1.29M | 1.05% | 17 |
|
|
2022
Q2 | $24.9M | Sell |
324,011
-14,400
| -4% | -$1.11M | 1.09% | 15 |
|
|
2022
Q1 | $24.7M | Buy |
338,411
+13,185
| +4% | +$963K | 0.97% | 23 |
|
|
2021
Q4 | $20.3M | Sell |
325,226
-8,622
| -3% | -$538K | 0.62% | 32 |
|
|
2021
Q3 | $19.8M | Sell |
333,848
-9,156
| -3% | -$542K | 0.64% | 33 |
|
|
2021
Q2 | $22.9M | Sell |
343,004
-17,500
| -5% | -$1.17M | 0.76% | 25 |
|
|
2021
Q1 | $22.8M | Sell |
360,504
-38,546
| -10% | -$2.43M | 0.8% | 29 |
|
|
2020
Q4 | $24.8M | Sell |
399,050
-62,907
| -14% | -$3.9M | 0.84% | 25 |
|
|
2020
Q3 | $27.9M | Sell |
461,957
-138,933
| -23% | -$8.38M | 0.91% | 22 |
|
|
2020
Q2 | $35.3M | Sell |
600,890
-122,832
| -17% | -$7.22M | 0.96% | 23 |
|
|
2020
Q1 | $40.3M | Buy |
723,722
+295,243
| +69% | +$16.5M | 1.21% | 21 |
|
|
2019
Q4 | $27.5M | Buy |
+428,479
| New | +$27.5M | 0.63% | 38 |
|